Could the Advanced Hybrid Closed-Loop System Algorithm Provide Postprandial Normoglycemia After a High-Fat, High-Protein Meal
NCT06848933 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2025-02-27
Summary
AHCL Systems Could Cover Postprandial Glycemic Response After High Fat and High Protein Meals
Conditions
- Type 1 Diabetes Mellitus
- Adolescents
Interventions
- OTHER
-
Test meal
On days 1, 2 and 3 of the study, a pediatric endocrinologist from the research team will evaluate the continuous glucose monitoring system data and optimize the carbohydrate/insulin ratios. On days 4 and 7 of the study, participants with blood sugar levels between 70-140 mg/dl according to the continuous glucose monitoring system, which is a component of the hybrid closed-loop insulin infusion pump system, will consume the test meal consisting of Dr Oetker Ristorante Pizza Mista (340 grams) (92 g carbohydrate, 33 g protein, 41 g fat) at lunch, under the supervision of a dietician from the research team, by switching the pump to manual mode and entering the carbohydrate amount of the meal into the pump. This application will be repeated on days 11 and 14 of the study, with the participant's pump in automatic mode. Participants will not be allowed to consume food or beverages other than water or exercise for 5 hours after the meal. Blood sugar monitoring will be done with the continuous
- DEVICE
-
Each participant will consume the test meal when on Medtronic Minimed 780G and will consume test meal on Medtronic Minimed 780G on manual mode
After the intervention, blood glucose values will be documented from continued glucose measurement system for postprandial 5 hours,and compared in manual mode and auto mode
- DEVICE
-
Advanced hybrid closed loop system mode
On days 1, 2 and 3 of the study, a pediatric endocrinologist from the research team will evaluate the continuous glucose monitoring system data and optimize the carbohydrate/insulin ratios. On days 4 and 7 of the study, participants with blood sugar levels between 70-140 mg/dl according to the continuous glucose monitoring system, which is a component of the hybrid closed-loop insulin infusion pump system, will consume the test meal consisting of Dr Oetker Ristorante Pizza Mista (340 grams) (92 g carbohydrate, 33 g protein, 41 g fat) at lunch, under the supervision of a dietician from the research team, by switching the pump to manual mode and entering the carbohydrate amount of the meal into the pump. This application will be repeated on days 11 and 14 of the study, with the participant's pump in automatic mode. Participants will not be allowed to consume food or beverages other than water or exercise for 5 hours after the meal. Blood sugar monitoring will be done with the continuous
Sponsors & Collaborators
-
Izmir Tinaztepe University
collaborator OTHER -
Ege University
lead OTHER
Principal Investigators
-
yasemin atik altınok, Assoc Prof · İzmir Tınaztepe University
-
Damla Goksen, Prof Dr · Ege University
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 9 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-01-05
- Primary Completion
- 2024-09-30
- Completion
- 2024-12-20
- FDA Device
- Yes
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Safety and Efficacy of Artificial Pancreas With and Without a Meal Detection Module on Glycemic Control in Adolescents With Type 1 Diabetes After a Missed Bolus
NCT02909829 ·Status: COMPLETED ·Phase: NA
-
Fake Carbs Practice With AID System - MiniMed 780G in Children and Adolescents With T1D.
NCT07179471 ·Status: RECRUITING
-
Four Way Crossover Closed Loop With Exercise Detection
NCT02862730 ·Status: COMPLETED ·Phase: NA
-
Closed-loop Control of Glucose Levels (Artificial Pancreas) for 24 Hours in Adults and Adolescents With Type 1 Diabetes
NCT01754337 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of Hybrid Closed Loop Systems in People With Type I Diabetes
NCT05348499 ·Status: UNKNOWN
-
Closed Loop From Onset in Type 1 Diabetes
NCT02871089 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Effect of Advanced Hybrid Closed Loop System, MiniMed 780G in Newly Diagnosed Children and Adolescents With Type 1 Diabetes on Glycemic Control and Patient Reported Outcomes Compared to Standard Insulin Therapy Historical Data (AHCL in New Onset T1D Children Study)
NCT06919029 ·Status: RECRUITING
-
Closed-loop Control of Glucose Levels (Artificial Pancreas) for 5 Days in Adults With Type 1 Diabetes
NCT02488616 ·Status: WITHDRAWN ·Phase: PHASE2
-
EFFECT OF HYBRID CLOSED-LOOP SYSTEMS ON CARDIOVASCULAR MARKERS IN TYPE 1 DIABETES.
NCT07241702 ·Status: ACTIVE_NOT_RECRUITING
-
ADvanced Hybrid Closed Loop Study in Adult Population With Type 1 Diabetes
NCT04235504 ·Status: COMPLETED ·Phase: NA
-
Hybrid Closed-Loop Control With Smart Prandial Insulin Dosing in Type 1 Diabetes
NCT04878120 ·Status: COMPLETED ·Phase: NA
-
Clinical Utility of Tight Objectives of Advanced Hybrid Closed-loop Systems Among Type 1 Diabetes Patients (TightT1AHCL)
NCT06466967 ·Status: COMPLETED
-
Diabeloop for Highly Unstable Type 1 Diabetes
NCT04042207 ·Status: COMPLETED ·Phase: NA
-
Maximising Time With a Normal Blood Glucose to Restore the Glucagon Response in Type 1 Diabetes
NCT04614168 ·Status: COMPLETED ·Phase: NA
-
The Impact of Hybrid Closed-loop Insulin Delivery in Type 1 Diabetes on Glycemic Control and PROMs
NCT04414280 ·Status: ACTIVE_NOT_RECRUITING
-
Simple Initiation of Advanced Hybrid Closed Loop System
NCT05069727 ·Status: COMPLETED ·Phase: NA
-
AHCL System Initiation in T1D Patients naïve to Technology
NCT04616391 ·Status: UNKNOWN ·Phase: NA
-
Diabetes Closed-Loop Project 6 (DCLP6): Fully Automated Closed-Loop Control in Type 1 Diabetes Using Meal Anticipation
NCT04877730 ·Status: COMPLETED ·Phase: NA
-
An Open-label, Two-center, Randomized, Cross-over Study to Evaluate the Safety and Efficacy of Glycemic Control Using Hybrid-closed Loop vs. Advanced Hybrid Closed-loop in Young Subjects With Type 1 Diabetes
NCT04269668 ·Status: COMPLETED ·Phase: NA
-
Optimizing Metabolic Control in Type 1 Diabetes - The Automatic Bolus Calculator Flash Study
NCT03682237 ·Status: COMPLETED ·Phase: NA
-
Dual-Hormone Closed-Loop Glucose Control in Adolescents With Type 1 Diabetes
NCT04949867 ·Status: COMPLETED ·Phase: PHASE4
-
Integration of Continuous Glucose Monitoring Into a BiHormonal Closed-Loop Artificial Pancreas
NCT01161862 ·Status: COMPLETED ·Phase: NA
-
Safety and Effectiveness Study of a Closed Loop System Maintaining Patients' Glucose Levels During an Overnight Period
NCT01712594 ·Status: COMPLETED ·Phase: NA
-
Choices and Experiences Around Closed-loop Therapy in Type 1 Diabetes
NCT07177404 ·Status: COMPLETED
-
Automated Closed-loop in Children and Adolescents With Type 1 Diabetes
NCT02129868 ·Status: COMPLETED ·Phase: NA